In re Relafen Antitrust Litigation
District Court, D. Massachusetts
1Opinion of the Court
MEMORANDUM
YOUNG, Chief Judge.
I. INTRODUCTION
By Order dated November 21, 2003, this Court allowed the end payor plaintiffs’ motion for class certification with respect to persons and entities who purchased nabumetone in five “exemplar” states. Order of 11/21/03 [Doc. No. 168 in Master File No. 01-12222-WGY] at 3, 5; see also In re Relafen Antitrust Litig., 221 F.R.D. 260 (D.Mass. 2004). The end payor plaintiffs, having since reached an agreement of settlement with SmithKline, now seek to extend certification to a nationwide settlement class. [Doe. No. 306]. To assist the parties in their…
2Cases cited34 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Landgraf v. USI Film ProductsSupreme Court of the United States · 1994
- Eisen v. Carlisle & JacquelinSupreme Court of the United States · 1974
- Illinois Brick Co. v. IllinoisSupreme Court of the United States · 1977
- Ortiz v. Fibreboard Corp.Supreme Court of the United States · 1999
29 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- Sheet Metal Workers Local 441 Health & Welfare Plan v. Glaxosmithkline, PLCDistrict Court, E.D. Pennsylvania · 2010
- In Re TFT-LCD (Flat Panel) Antitrust LitigationDistrict Court, N.D. California · 2009
- In re Relafen Antitrust LitigationDistrict Court, D. Massachusetts · 2005
- Meijer, Inc. v. Ferring B.V.District Court, S.D. New York · 2012
- California v. Infineon Technologies AGDistrict Court, N.D. California · 2007
5 more not listed; retrieve them via the Exa API.